Jonathan P Winickoff1, Robert McMillen2, Susanne Tanski3, Karen Wilson4, Mark Gottlieb5, Robert Crane6. 1. American Academy of Pediatrics, Julius B. Richmond Center of Excellence, Elk Grove Village, Illinois, USA MassGeneral Hospital Division of General Pediatrics and Harvard Medical School. 2. American Academy of Pediatrics, Julius B. Richmond Center of Excellence, Elk Grove Village, Illinois, USA Mississippi State University, Starkville, Mississippi, USA. 3. Giesel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. 4. University of Colorado, Children's Hospital Colorado, Aurora, Colorado, USA. 5. Public Health Advocacy Institute, Boston, Massachusetts, USA. 6. Ohio State University, Columbus, Ohio, USA.
Abstract
OBJECTIVES: The vast majority of tobacco users began before the age of 21. Raising the tobacco sales age to 21 has the potential to reduce tobacco use initiation and progression to regular smoking. Our objective was to assess the level of public support nationally for 'Tobacco 21' initiatives in the USA. METHODS: The Social Climate Survey of Tobacco Control, a cross-sectional dual-frame survey representing national probability samples of adults was administered in 2013. Respondents were asked to state their agreement level with, 'The age to buy tobacco should be raised to 21.' RESULTS: Of 3245 respondents, 70.5% support raising the age to buy tobacco to 21. The majority of adults in every demographic and smoking status category supported raising the tobacco sales age to 21. In multivariable analyses, support was highest among never smokers, females, African-Americans and older adults. CONCLUSIONS: This national study demonstrates broad public support for raising the sales age of tobacco to 21 and will help facilitate wide dissemination of initiatives to increase the legal purchase age at national, state and local levels. Increasing public awareness about the susceptibility and rapid addiction of youth to nicotine may further increase public support for raising the tobacco sale age to 21. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVES: The vast majority of tobacco users began before the age of 21. Raising the tobacco sales age to 21 has the potential to reduce tobacco use initiation and progression to regular smoking. Our objective was to assess the level of public support nationally for 'Tobacco 21' initiatives in the USA. METHODS: The Social Climate Survey of Tobacco Control, a cross-sectional dual-frame survey representing national probability samples of adults was administered in 2013. Respondents were asked to state their agreement level with, 'The age to buy tobacco should be raised to 21.' RESULTS: Of 3245 respondents, 70.5% support raising the age to buy tobacco to 21. The majority of adults in every demographic and smoking status category supported raising the tobacco sales age to 21. In multivariable analyses, support was highest among never smokers, females, African-Americans and older adults. CONCLUSIONS: This national study demonstrates broad public support for raising the sales age of tobacco to 21 and will help facilitate wide dissemination of initiatives to increase the legal purchase age at national, state and local levels. Increasing public awareness about the susceptibility and rapid addiction of youth to nicotine may further increase public support for raising the tobacco sale age to 21. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Summer Sherburne Hawkins; Janet Chung-Hall; Lorraine Craig; Geoffrey T Fong; Ron Borland; K Michael Cummings; David Levy; Sara C Hitchman Journal: Nicotine Tob Res Date: 2020-12-12 Impact factor: 4.244
Authors: Joseph G L Lee; Marcella H Boynton; Amanda Richardson; Kristen Jarman; Leah M Ranney; Adam O Goldstein Journal: Am J Prev Med Date: 2016-06-01 Impact factor: 5.043
Authors: David C Colston; Andrea R Titus; James F Thrasher; Michael R Elliott; Nancy L Fleischer Journal: Am J Prev Med Date: 2020-11-05 Impact factor: 5.043
Authors: Kelly D Blake; Anna Gaysynsky; Rachel Grana Mayne; Andrew B Seidenberg; Annette Kaufman; Heather D'Angelo; Maria Roditis; Robert E Vollinger Journal: Prev Med Date: 2021-12-24 Impact factor: 4.018
Authors: Shawna V Hudson; Marin Kurti; Jenna Howard; Bianca Sanabria; Kevin R J Schroth; Mary Hrywna; Cristine D Delnevo Journal: Int J Environ Res Public Health Date: 2021-06-05 Impact factor: 3.390